Title |
Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model
|
---|---|
Published in |
ClinicoEconomics and Outcomes Research: CEOR, April 2012
|
DOI | 10.2147/ceor.s31238 |
Pubmed ID | |
Authors |
Tamlyn Anne Rautenberg, Ute Zerwes, Douglas Foerster, Rick Aultman |
Abstract |
The safety and efficacy of racecadotril to treat acute watery diarrhea (AWD) in children is well established, however its cost effectiveness for infants and children in Europe has not yet been determined. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 2% |
Unknown | 44 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 18% |
Researcher | 8 | 18% |
Student > Master | 6 | 13% |
Student > Bachelor | 5 | 11% |
Other | 3 | 7% |
Other | 10 | 22% |
Unknown | 5 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 40% |
Nursing and Health Professions | 7 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
Unspecified | 2 | 4% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 6 | 13% |
Unknown | 7 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2013.
All research outputs
#8,127,820
of 25,806,080 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#184
of 527 outputs
Outputs of similar age
#52,567
of 173,865 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#3
of 9 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,865 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.